Drug Repurposing for COVID-19: Current Status of Potential Therapeutics
Pravalika Avirineni,
Sudheer K. Dundigalla,
Satyanarayana S. V. Padi
Abstract:The maneuver clinical investigation of an effective drug for coronavirus disease 2019 (COVID-19) is still ongoing and the milieu of a successful investigational drug with proven efficacy is still obscure. Drug repurposing is a method to identify new therapeutic uses for existing drugs, which include approved, delayed, withdrawn, and investigational drugs and drug candidates. Indeed, the cost of the standard drug discovery and development process amounts to more than a billion dollars, and the investigations ar… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.